Streetbeat News

Analyst Ratings

ROST

A significant bullish stance has been taken on Ross Stores (NASDAQ:ROST) as evidenced by unusual options activity. The overall sentiment of these big-money traders is split between 66% bullish and 33% bearish. The whales have been targeting a price range from $116.0 to $120.0 for Ross Stores over the last 3 months. The price of ROST is up 0.75% at $114.03, with RSI indicators hinting that the stock may be approaching overbought. The next earnings are expected to be released in 8 days.

Portfolio Pulse from Benzinga Insights

August 09, 2023 | 3:16 pm

BP

A significant bullish stance on BP (NYSE:BP) has been observed, with unusual options activity. The sentiment among these big-money traders is 80% bullish and 20% bearish. The price target for BP over the last 3 months has been between $25.0 to $42.0. Raymond James has maintained their Outperform rating on BP, with a price target of $45.

Portfolio Pulse from Benzinga Insights

August 09, 2023 | 3:16 pm

INTC

A significant investor has taken a bearish stance on Intel (NASDAQ:INTC), with 75% of recent trades reflecting bearish expectations. The trades include 2 puts worth $77,800 and 10 calls worth $656,084. The targeted price range for Intel over the last 3 months has been $27.5 to $45.0. The current price of INTC is down -0.71% at $34.77. Analysts' ratings vary, with Wolfe Research maintaining an Underperform rating and a price target of $31, while Tigress Financial has downgraded its action to Buy with a price target of $46.

Portfolio Pulse from Benzinga Insights

August 09, 2023 | 3:16 pm

USM

Wells Fargo analyst Eric Luebchow has upgraded United States Cellular (NYSE:USM) from Underweight to Equal-Weight and raised the price target from $16 to $38.

Portfolio Pulse from Benzinga Newsdesk

August 09, 2023 | 3:14 pm

CI

CVS

LLY

NVO

UNH

Novo Nordisk's weight loss drug, semaglutide, has shown a 20% reduction in major adverse cardiovascular events in a large scale study. This has positive implications for Eli Lilly's similar weight loss drug, Mounjaro. However, the prospect of insurers needing to cover these expensive drugs has led to a fall in stocks of health insurers like UnitedHealth Group, Cigna Group, and CVS Health Corp. Eli Lilly has reported strong earnings and raised its FY23 guidance. The company also has a promising Alzheimer's drug in the pipeline.

Portfolio Pulse from The Arora Report

August 09, 2023 | 3:10 pm

TDG

RBC Capital analyst Ken Herbert maintains an Outperform rating on TransDigm Gr (NYSE:TDG) and raises the price target from $920 to $975.

Portfolio Pulse from richadhand@benzinga.com

August 09, 2023 | 3:08 pm

ZVIA

Morgan Stanley analyst Dara Mohsenian has maintained an Equal-Weight rating on Zevia (NYSE:ZVIA) and lowered the price target from $3.5 to $3.25.

Portfolio Pulse from Benzinga Newsdesk

August 09, 2023 | 3:07 pm

SQSP

RBC Capital analyst Brad Erickson maintains a 'Sector Perform' rating on Squarespace (NYSE:SQSP) and raises the price target from $30 to $32.

Portfolio Pulse from richadhand@benzinga.com

August 09, 2023 | 3:06 pm

WMG

Morgan Stanley analyst Benjamin Swinburne has maintained an Overweight rating on Warner Music Group (NASDAQ:WMG) and raised the price target from $34 to $38.

Portfolio Pulse from Benzinga Newsdesk

August 09, 2023 | 3:06 pm

SEE

RBC Capital analyst Arun Viswanathan has maintained an 'Outperform' rating on Sealed Air (NYSE:SEE) but lowered the price target from $47 to $45.

Portfolio Pulse from richadhand@benzinga.com

August 09, 2023 | 3:06 pm